Fennec Pharmaceuticals (FENC) EPS (Basic) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.92% |
| Sep 30, 2025 | 39.16% |
| Jun 30, 2025 | 12.13% |
| Mar 31, 2025 | 26.77% |
| Dec 31, 2024 | 14.97% |
| Sep 30, 2024 | -18.47% |
| Jun 30, 2024 | 3.58% |
| Mar 31, 2024 | 27.41% |
| Dec 31, 2023 | 7.79% |
| Sep 30, 2023 | 12.94% |
| Jun 30, 2023 | -8.45% |
| Mar 31, 2023 | -20.64% |
| Dec 31, 2022 | -10.76% |
| Sep 30, 2022 | -15.63% |
| Jun 30, 2022 | -11.55% |
| Mar 31, 2022 | -18.47% |
| Dec 31, 2021 | -13.56% |
| Sep 30, 2021 | -31.95% |
| Jun 30, 2021 | -20.11% |
| Mar 31, 2021 | -35.10% |
| Dec 31, 2020 | -19.14% |
| Sep 30, 2020 | -88.82% |
| Jun 30, 2020 | -60.04% |
| Mar 31, 2020 | -62.98% |
| Dec 31, 2019 | -26.86% |
| Sep 30, 2019 | -33.56% |
| Jun 30, 2019 | -24.57% |
| Mar 31, 2019 | 19.38% |
| Dec 31, 2018 | -28.47% |
| Sep 30, 2018 | 7.79% |
| Jun 30, 2018 | -20.48% |
| Mar 31, 2018 | 10.87% |
| Dec 31, 2017 | 10.42% |
| Sep 30, 2017 | -37.97% |
| Jun 30, 2017 | -40.63% |
| Mar 31, 2017 | -20.55% |
| Dec 31, 2016 | -21.06% |
| Sep 30, 2016 | 25.13% |
| Jun 30, 2016 | -43.10% |
| Mar 31, 2016 | -16.80% |
| Dec 31, 2015 | 31.01% |
| Sep 30, 2015 | -16.27% |
| Jun 30, 2015 | -14.87% |